Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib Monotherapy in Neuroendocrine Tumor
NCT01099540Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Apr 2010
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in Neuroendocrine Neoplasm (NEN), sponsored by Samsung Medical Center. Started Apr 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT01099540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099540.